药物信息为Visicol (Salix Pharmaceuticals, Inc.): DESCRIPTION
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- CLINICAL STUDIES
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- WARNINGS
- Adverse Reactions
- OVERDOSAGE
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- 外部链接相关的Visicol (Salix Pharmaceuticals, Inc.)
Visicol® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) is a purgative used to clean the colon prior to colonoscopy. Visicol® Tablets are white to off-white compressed tablets, with a monogram "I" on each side of the upper surface and a plain lower surface. Each tablet contains 1.102 grams of sodium phosphate monobasic monohydrate, USP and 0.398 grams of sodium phosphate dibasic anhydrous, USP for a total of 1.5 grams of sodium phosphate per tablet. Inert ingredients include microcrystalline cellulose (MCC), NF; magnesium stearate, NF; and colloidal silicon dioxide, NF. Visicol® is gluten-free.
The structural and molecular formulae and molecular weights of the active ingredients are shown below:
- Sodium phosphate monobasic monohydrate, USP
Molecular Formula: NaH2PO4•H2O Molecular Weight: 137.99
- Sodium phosphate dibasic anhydrous, USP
Molecular Formula: Na2HPO4 Molecular Weight: 141.96
Visicol® Tablets are for oral administration only.
- Sodium phosphate monobasic monohydrate, USP
- Drug Information Provided by National Library of Medicine (NLM).
